dosing emulsion

Polish translation: (DSP-7888) Dosing Emulsion

GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW)
English term or phrase:dosing emulsion
Polish translation:(DSP-7888) Dosing Emulsion
Entered by: Frank Szmulowicz, Ph. D.

13:53 Jun 13, 2018
English to Polish translations [PRO]
Medical - Medical (general) / badania kliniczne
English term or phrase: dosing emulsion
Wyrażenie pochodzi z formularza zgody na udział w badaniu klinicznym.
Randomized, Multicenter Study of XXX Dosing Emulsion
This study will help us learn more about a newly discovered vaccine drug, XXX Dosing Emulsion (or simply XXX).
Kaskaj
(DSP-7888) Dosing Emulsion
Explanation:
To jest nazywa własna i nie powinna być tłumaczona.

This is a multicenter, open label, Phase 1 dose-escalation study of DSP-7888 Dosing Emulsion administered to adult patients with advanced malignancies. Patients will be administered escalating doses of DSP-7888 Dosing Emulsion intradermally or subcutaneously in accordance with the following regimen: once weekly for four weeks during the Induction Phase, once every 7 to 14 days for 6 weeks during the Consolidation Phase, and once every 14 to 28 days until a discontinuation criterion is met during the Maintenance Phase. Once RP2D is determined from either the intradermal or subcutaneous group, an additional 40 patients evaluable for response may be enrolled as an expansion cohort at this dose and route of administration to confirm safety and tolerability. Separate from the dose-ascending cohort and RP2D expansion cohort described previously, and once the intradermal dose-ascending cohort is completed, up to 20 MDS patients who are refractory to treatment with hypomethylating agents (HMAs) will be enrolled into an MDS expansion cohort. Of these 20 MDS patients, one-half will receive DSP-7888 at 10.5 mg according to the modified schedule employed in Phase 1 (every week for 4 weeks, every 2 weeks until Week 24, and then every 4 weeks; [MDS Cohort 1]). The other half of the MDS patients will receive DSP-7888 at 10.5 mg in an alternative dosing schedule where DSP-7888 is administered every 2 weeks until Week 24, after which it will be administered every 4 weeks (MDS Cohort 2).
https://clinicaltrials.gov/ct2/show/NCT02498665
Selected response from:

Frank Szmulowicz, Ph. D.
United States
Local time: 19:06
Grading comment
Dziękuję
4 KudoZ points were awarded for this answer



Summary of answers provided
3(DSP-7888) Dosing Emulsion
Frank Szmulowicz, Ph. D.


  

Answers


55 mins   confidence: Answerer confidence 3/5Answerer confidence 3/5
(DSP-7888) Dosing Emulsion


Explanation:
To jest nazywa własna i nie powinna być tłumaczona.

This is a multicenter, open label, Phase 1 dose-escalation study of DSP-7888 Dosing Emulsion administered to adult patients with advanced malignancies. Patients will be administered escalating doses of DSP-7888 Dosing Emulsion intradermally or subcutaneously in accordance with the following regimen: once weekly for four weeks during the Induction Phase, once every 7 to 14 days for 6 weeks during the Consolidation Phase, and once every 14 to 28 days until a discontinuation criterion is met during the Maintenance Phase. Once RP2D is determined from either the intradermal or subcutaneous group, an additional 40 patients evaluable for response may be enrolled as an expansion cohort at this dose and route of administration to confirm safety and tolerability. Separate from the dose-ascending cohort and RP2D expansion cohort described previously, and once the intradermal dose-ascending cohort is completed, up to 20 MDS patients who are refractory to treatment with hypomethylating agents (HMAs) will be enrolled into an MDS expansion cohort. Of these 20 MDS patients, one-half will receive DSP-7888 at 10.5 mg according to the modified schedule employed in Phase 1 (every week for 4 weeks, every 2 weeks until Week 24, and then every 4 weeks; [MDS Cohort 1]). The other half of the MDS patients will receive DSP-7888 at 10.5 mg in an alternative dosing schedule where DSP-7888 is administered every 2 weeks until Week 24, after which it will be administered every 4 weeks (MDS Cohort 2).
https://clinicaltrials.gov/ct2/show/NCT02498665

Frank Szmulowicz, Ph. D.
United States
Local time: 19:06
Native speaker of: Native in EnglishEnglish, Native in PolishPolish
PRO pts in category: 1349
Grading comment
Dziękuję
Notes to answerer
Asker: Dziękuję.

Login to enter a peer comment (or grade)



Login or register (free and only takes a few minutes) to participate in this question.

You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.

KudoZ™ translation help

The KudoZ network provides a framework for translators and others to assist each other with translations or explanations of terms and short phrases.


See also:

Your current localization setting

English

Select a language

Term search
  • All of ProZ.com
  • Term search
  • Jobs
  • Forums
  • Multiple search